Marco joined the Mundipharma network of independent associated companies in 2018 further enhance our external partnerships and medicine pipeline. Prior to joining Mundipharma Marco was Head of Business Development and Licensing at Helsinn and previously served as Head of Licensing for late stage assets since January 2016. Marco has significant commercial, development and strategic leadership expertise from an 11-year career in the pharmaceutical industry, with a specific focus on cancer supportive care and oncology. In his tenure at Helsinn he oversaw more than 50 licensing deals covering more than 190 countries around the world across cancer supportive care and oncology.
Marco holds a degree in Biotechnologies and a specialisation in industrial biotechnologies completed by an executive made to measure Master course in Business Administration from the Bocconi School of Management
Press return to search